NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 72 filers reported holding NEXTCURE INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,078 | -43.8% | 58,200 | -21.6% | 0.00% | – |
| Q2 2023 | $133,560 | -15.5% | 74,200 | -30.5% | 0.00% | – |
| Q1 2023 | $158,064 | -21.2% | 106,800 | -24.9% | 0.00% | -100.0% |
| Q4 2022 | $200,643 | -52.3% | 142,300 | -7.1% | 0.00% | 0.0% |
| Q3 2022 | $421,000 | -13.6% | 153,200 | +47.9% | 0.00% | 0.0% |
| Q2 2022 | $487,000 | -3.2% | 103,600 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $503,000 | -47.2% | 103,500 | -34.9% | 0.00% | -50.0% |
| Q4 2021 | $953,000 | -28.9% | 158,900 | -20.2% | 0.00% | -33.3% |
| Q3 2021 | $1,341,000 | +75.1% | 199,000 | +108.6% | 0.00% | +50.0% |
| Q2 2021 | $766,000 | -32.7% | 95,400 | -16.2% | 0.00% | -33.3% |
| Q1 2021 | $1,139,000 | +22.2% | 113,800 | +33.1% | 0.00% | +50.0% |
| Q4 2020 | $932,000 | -38.9% | 85,500 | -50.7% | 0.00% | -50.0% |
| Q3 2020 | $1,525,000 | +131.8% | 173,300 | +464.5% | 0.00% | +100.0% |
| Q2 2020 | $658,000 | – | 30,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |